Purinergic Signalling

杂志介绍

Purinergic Signalling杂志介绍

《Purinergic Signalling》是一本以English为主的未开放获取国际优秀期刊，中文名称嘌呤能信号，本刊主要出版、报道医学-神经科学领域的研究动态以及在该领域取得的各方面的经验和科研成果，介绍该领域有关本专业的最新进展，探讨行业发展的思路和方法，以促进学术信息交流，提高行业发展。该刊已被国际权威数据库SCIE、SCI收录，为该领域相关学科的发展起到了良好的推动作用，也得到了本专业人员的广泛认可。该刊最新影响因子为3.065，最新CiteScore 指数为5.7。

本刊近期中国学者发表的论文主要有：

• Purinergic signaling: a potential therapeutic target for depression and chronic pai

  Author:

• Purinergic ATP triggers moxibustion-induced local anti-nociceptive effect on inflammatory pain mode

  Author:

• In silico identification of A1 agonists and A2a inhibitors in pain based on molecular docking strategies and dynamics simulation

  Author:

• Inhibition of phosphorylated calcium/calmodulin-dependent protein kinase II alpha relieves streptozotocin-induced diabetic neuropathic pain through regulation of P2X3 receptor in dorsal root gangli

  Author:

英文介绍

Purinergic Signalling杂志英文介绍

Nucleotides and nucleosides are primitive biological molecules that were utilized early in evolution both as intracellular energy sources and as extracellular signalling molecules. ATP was first identified as a neurotransmitter and later as a co-transmitter with all the established neurotransmitters in both peripheral and central nervous systems. Four subtypes of P1 (adenosine) receptors, 7 subtypes of P2X ion channel receptors and 8 subtypes of P2Y G protein-coupled receptors have currently been identified. Since P2 receptors were first cloned in the early 1990’s, there is clear evidence for the widespread distribution of both P1 and P2 receptor subtypes in neuronal and non-neuronal cells, including glial, immune, bone, muscle, endothelial, epithelial and endocrine cells.